Pharma News, 2020

San Diego-based Retrophin is buying Orphan Technologies for $90 million in cash up front.

HELLERUP, Denmark, Oct.

A succession of deaths following flu shots — 28 reported as of Thursday — is fanning fears over the safety of Korean influenza vaccinations, though the government insists a link remains unproven.

ADDIS ABABA (Reuters) - The African Export Import Bank is ready to raise up to $5 billion to purchase COVID-19 vaccines for African countries, the head of the continent’s disease control bod...

Today, the U.

PHILADELPHIA--(BUSINESS WIRE)-- In response to the pharmaceutical giant Mallinckrodt Pharmaceuticals bankruptcy filing last week, Delaware Valley Health Care Coalition, Inc.

University of Cambridge spin-out company STORM Therapeutics has announced that it has selected a first-in-class METTL3 candidate for development towards first in human clinical studies.

In the future, this model could be applied to a consented phone conversation, or through an app on a mobile phone, Ajay Royyuru said.

Highly respected Professor Peter Doshi, Ph.

Liquid biopsy company ANGLE has announced that the US Food and Drug Administration has accepted its submission for substantive review of its Parsortix system for use with metastatic breast cancer (...

EMA has recommended the granting of marketing authorisations for two new antiretroviral (ARV) medicines, Rekambys (rilpivirine) and Vocabria injection (cabotegravir), to be use...

WOONSOCKET, R.